ClearPoint Neuro Inc. (CLPT)
NASDAQ: CLPT
· Real-Time Price · USD
25.28
0.45 (1.81%)
At close: Oct 16, 2025, 3:59 PM
25.36
0.32%
After-hours: Oct 16, 2025, 07:41 PM EDT
1.81% (1D)
| Bid | 24.56 |
| Market Cap | 718.65M |
| Revenue (ttm) | 33.59M |
| Net Income (ttm) | -22.22M |
| EPS (ttm) | -0.8 |
| PE Ratio (ttm) | -31.6 |
| Forward PE | -38.28 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 25.8 |
| Volume | 700,400 |
| Avg. Volume (20D) | 786,814 |
| Open | 25.00 |
| Previous Close | 24.83 |
| Day's Range | 24.20 - 25.57 |
| 52-Week Range | 9.76 - 30.10 |
| Beta | 1.19 |
| Ex-Dividend Date | n/a |
About CLPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsClearPoint Neuro Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+12.16%
ClearPoint Neuro shares are trading higher after t...
Unlock content with
Pro Subscription
2 weeks ago
+19.8%
ClearPoint Neuro shares are trading higher after the company announced the development and demonstration of its Robotic Neuro-Navigation System.
3 weeks ago · accessnewswire.com
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical OfficerSOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 25, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise naviga...
